Yahoo Web Search

Search results

    • Analyst Report: Biogen Inc.

      Morningstar Research via Yahoo Finance· 14 hours ago

      Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation ...